|
Good Communication Can Minimize Disruptions During IRB Transfers
To smoothly transition clinical investigation oversight from one IRB to another, new and old IRBs, clinical investigators, sponsors and CROs should work closely to minimize disruptions to the ongoing trial and ensure subjects are constantly protected, according to a new draft guidance.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives